Systematic review and subgroup analysis of the incidence of acute kidney injury (AKI) in patients with COVID-19

BACKGROUND: Acute kidney injury (AKI) occurs among patients with coronavirus disease-19 (COVID-19) and has also been indicated to be associated with in-hospital mortality. Remdesivir has been authorized for the treatment of COVID-19. We conducted a systematic review to evaluate the incidence of AKI...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zhenjian, Tang, Ying, Huang, Qiuyan, Fu, Sha, Li, Xiaomei, Lin, Baojuan, Xu, Anping, Chen, Junzhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863041/
https://www.ncbi.nlm.nih.gov/pubmed/33546616
http://dx.doi.org/10.1186/s12882-021-02244-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863041/
https://www.ncbi.nlm.nih.gov/pubmed/33546616
http://dx.doi.org/10.1186/s12882-021-02244-x

Ejemplares similares